Butyl Alcohol

Butyl Alcohol

SCHEMBL9949079

CCCCCCNC.CCCCO

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 6/20 0.75
ALDH1A1 P00352 3/20 0.57
LMNA P02545 2/20 0.57
TSHR P16473 2/20 0.57
HSD17B10 Q99714 1/20 0.57
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.52
S1PR2 O95136 5/20 0.47
S1PR4 O95977 5/20 0.47
S1PR1 P21453 5/20 0.47
S1PR3 Q99500 5/20 0.47
NAAA Q02083 1/20 0.47
S1PR5 Q9H228 1/20 0.47
LPAR2 Q9HBW0 1/20 0.41
LPAR3 Q9UBY5 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyl Alcohol SCHEMBL9949555 1.00 EPHX1 (0.75) EPHX1ALDH1A1LMNATSHRHSD17B10
Butyl Alcohol SCHEMBL9950788 1.00 EPHX1 (0.75) EPHX1ALDH1A1LMNATSHRHSD17B10
Butyl Alcohol SCHEMBL9949696 1.00 EPHX1 (0.75) EPHX1ALDH1A1LMNATSHRHSD17B10
Butyl Alcohol SCHEMBL9949488 0.97 EPHX1 (0.70) EPHX1ALDH1A1LMNATSHRHSD17B10
1-Hexanol SCHEMBL11679418 0.93 EPHX1 (0.71) EPHX1ALDH1A1LMNATSHRHSD17B10
Propanol SCHEMBL9949383 0.92 EPHX1 (0.79) EPHX1ALDH1A1LMNATSHRHSD17B10
Propanol SCHEMBL1176412 0.92 EPHX1 (0.79) EPHX1ALDH1A1LMNATSHRHSD17B10
Propanol SCHEMBL9949752 0.92 EPHX1 (0.79) EPHX1ALDH1A1LMNATSHRHSD17B10
Propanol SCHEMBL9949577 0.92 EPHX1 (0.79) EPHX1ALDH1A1LMNATSHRHSD17B10
Propanol SCHEMBL9950933 0.92 EPHX1 (0.79) EPHX1ALDH1A1LMNATSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2705894-B1 Acid gas absorbent, acid gas removal method and acid gas removal device TOSHIBA KK (JP) 2018-05-23 EP disclosed
EP-2784059-B1 Method for isolating tertiary amino alcohol TOSHIBA KK (JP) 2016-08-24 EP disclosed
US-9409119-B2 Acid gas absorbent, acid gas removal method, and acid gas removal device KABUSHIKI KAISHA TOSHIBA (JP) 2016-08-09 US disclosed
US-9181174-B2 Method for isolating tertiary amino alcohol KABUSHIKI KAISHA TOSHIBA (JP) 2015-11-10 US disclosed
US-20140296576-A1 METHOD FOR ISOLATING TERTIARY AMINO ALCOHOL KABUSHIKI KAISHA TOSHIBA (JP) 2014-10-02 US disclosed
EP-2784059-A1 Method for isolating tertiary amino alcohol Kabushiki Kaisha Toshiba (JP) 2014-10-01 EP disclosed
EP-2705894-A1 Acid gas absorbent, acid gas removal method and acid gas removal device Kabushiki Kaisha Toshiba (JP) 2014-03-12 EP disclosed
US-20120161071-A1 ACID GAS ABSORBENT, ACID GAS REMOVAL METHOD, AND ACID GAS REMOVAL DEVICE KABUSHIKI KAISHA TOSHIBA (JP) 2012-06-28 US disclosed
EP-2468385-A2 Acid gas absorbent, acid gas removal method and acid gas removal device Kabushiki Kaisha Toshiba (JP) 2012-06-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296576-A1 METHOD FOR ISOLATING TERTIARY AMINO ALCOHOL ADH1C, AADAT, ADH1A EPHX1 1763/4885ALDH1A1 48/4885LMNA 528/4885
US-20120161071-A1 ACID GAS ABSORBENT, ACID GAS REMOVAL METHOD, AND ACID GAS REMOVAL DEVICE ALKBH1, ALKBH3, ALKBH2 EPHX1 133/4885ALDH1A1 247/4885LMNA 4049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.